In recent years, biopharma has paid significantly different prices for the same underlying technology. In March 2025, AstraZeneca agreed to pay EsoBiotec, an in vivo CAR-T platform with early single-patient data, $425 million upfront and up to $575 million more in milestones. In August 2025, Gilead’s Kite paid $350 million for Interius BioTherapeutics, another in vivo CAR-T platform, also…
More than half of the 2,500-plus deaths from DR Congo's Ebola outbreak have occurred within the past 20 days alone, as the virus spreads faster than any recorded outbreak, according to the UN's senior…
A Senior Lecturer at the University of Ghana School of Public Health, Mr. John Arko Mensah, is warning farmers to wear nose masks and protective equipment when spraying chemicals, saying exposure to…
A Senior Lecturer at the University of Ghana School of Public Health, Mr. John Arko Mensah, is warning farmers to wear nose masks and protective equipment when spraying chemicals, saying exposure to…
In the late 1990s, a young Michael Kahana—then developing computer models of human memory—was invited to Harvard Medical School by a neurosurgeon friend to give grand rounds to the neurosurgery and…
The biopharma industry tipped the scales on cancer research years ago. Where the federal government once played a major role in determining what was studied in clinical trials, industry players took a…
New research published in Brain Imaging and Behavior suggests that estradiol influences how brain areas communicate during memory tasks in middle-aged women.
